These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. Autrup H, Seremet T, Wakhisi J, Wasunna A. Cancer Res; 1987 Jul 01; 47(13):3430-3. PubMed ID: 3034416 [Abstract] [Full Text] [Related]
37. Delta agent and hepatocellular carcinoma. Craxì A, Raimondo G, Giannuoli G, Longo G, Caltagirone M, Aragona M, Squadrito G, Pagliaro L. Prog Clin Biol Res; 1983 Jul 01; 143():231-4. PubMed ID: 6322197 [No Abstract] [Full Text] [Related]
38. Aflatoxin B 1 , a hepatocarcinogen in the infant mouse. Vesselinovitch SD, Mihailovich N, Wogan GN, Lombard LS, Rao KV. Cancer Res; 1972 Nov 01; 32(11):2289-91. PubMed ID: 4343225 [No Abstract] [Full Text] [Related]
39. Aflatoxins in liver biopsies from Kenya. De Vries HR, Lamplugh SM. Trop Geogr Med; 1989 Jan 01; 41(1):26-30. PubMed ID: 2548310 [Abstract] [Full Text] [Related]
40. Hepatocellular carcinoma and cirrhosis in Thailand: etiologic considerations of underlying cirrhosis. Suwangool P. J Med Assoc Thai; 1980 May 01; 63(5):245-9. PubMed ID: 6248611 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]